Abstract
In this work we studied the tumor effect of fructose and glucose on the mice xenotransplant model of sarcoma 180 (S180) in in vivo. The experimental results suggest that for dosages of 14 mg/kg and 28 mg/kg glucose (and fructose in a lower rate) show a great inhibitory behavior on tumors.
Keywords: Fructose, glucose, tumors, phenotypes, metabolism, ether, diabetics, tree fruits, melons
Letters in Organic Chemistry
Title: A Comparative Study of Glucose and Fructose in the Development of Sarcoma 180 in Mice
Volume: 8 Issue: 8
Author(s): G. S. Paiva, Carlton A. Taft and Ivone A. de Souza
Affiliation:
Keywords: Fructose, glucose, tumors, phenotypes, metabolism, ether, diabetics, tree fruits, melons
Abstract: In this work we studied the tumor effect of fructose and glucose on the mice xenotransplant model of sarcoma 180 (S180) in in vivo. The experimental results suggest that for dosages of 14 mg/kg and 28 mg/kg glucose (and fructose in a lower rate) show a great inhibitory behavior on tumors.
Export Options
About this article
Cite this article as:
S. Paiva G., A. Taft Carlton and A. de Souza Ivone, A Comparative Study of Glucose and Fructose in the Development of Sarcoma 180 in Mice, Letters in Organic Chemistry 2011; 8 (8) . https://dx.doi.org/10.2174/157017811797249407
DOI https://dx.doi.org/10.2174/157017811797249407 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nitroimidazole Radiopharmaceuticals in Hypoxia: Part II Cytotoxicity and Radiosensitization Applications
Current Radiopharmaceuticals Recent Advances in Biotransformation by Cunninghamella Species
Current Drug Metabolism Patent Selections
Recent Patents on Biomarkers Angiogenesis and Angiogenesis Inhibitors: a New Potential Anticancer Therapeutic Strategy
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Arsenic-exposed Keratinocytes Exhibit Differential microRNAs Expression Profile; Potential Implication of miR-21, miR-200a and miR-141 in Melanoma Pathway
Clinical Cancer Drugs Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as a New Lead for Treating Breast and Ovarian Cancer
Current Drug Targets The Novel VEGF<sub>121</sub>-VEGF<sub>165</sub> Fusion Attenuates Angiogenesis and Drug Resistance via Targeting VEGFR2-HIF-1α-VEGF<sub>165</sub>/Lon Signaling Through PI3K-AKT-mTOR Pathway
Current Cancer Drug Targets Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling
Current Drug Targets Osteoporosis in Patients with Breast and Prostate Cancer: Effect of Disease and Treatment Modalities
Endocrine, Metabolic & Immune Disorders - Drug Targets Combined Anticancer Therapies: An Overview of the Latest Applications
Anti-Cancer Agents in Medicinal Chemistry Innovative Cancer Treatments that Augment Radiotherapy or Chemotherapy by the Use of Immunotherapy or Gene Therapy
Recent Patents on Anti-Cancer Drug Discovery Dietary Phytochemicals in Chemoprevention of Cancer: An Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Bladder Cancer: Update on Risk Factors, Molecular and Ultrastructural Patterns
Current Medicinal Chemistry Application of Phage Display Technology to Cancer Research
Current Pharmaceutical Biotechnology New Insights on Fak and Fak Inhibitors
Current Medicinal Chemistry Cathepsin D as a Promising Target for the Discovery of Novel Anticancer Agents
Current Cancer Drug Targets Targeting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cells
Current Medicinal Chemistry Antiangiogenic Therapy for High-Grade Gliomas
CNS & Neurological Disorders - Drug Targets Survivin: Role in Normal Cells and in Pathological Conditions
Current Cancer Drug Targets Hematopoietic Stem Cells Therapies
Current Stem Cell Research & Therapy